Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 5, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-08-05
DOI
10.3389/fneur.2014.00144
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys
- (2015) Nicolas Morin et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Therapeutic potential of targeting glutamate receptors in Parkinson’s disease
- (2014) Clare Finlay et al. JOURNAL OF NEURAL TRANSMISSION
- GluN2D-containing NMDA receptors inhibit neurotransmission in the mouse striatum through a cholinergic mechanism: implication for Parkinson's disease
- (2014) Xiaoqun Zhang et al. JOURNAL OF NEUROCHEMISTRY
- Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys
- (2014) Nicolas Morin et al. NEUROPHARMACOLOGY
- Advances in non-dopaminergic treatments for Parkinson's disease
- (2014) Sandy Stayte et al. Frontiers in Neuroscience
- Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia
- (2013) Golnasim Riahi et al. BIOCHEMICAL PHARMACOLOGY
- Modeling dyskinesia in animal models of Parkinson disease
- (2013) Nicolas Morin et al. EXPERIMENTAL NEUROLOGY
- Glycine site agonists of theN-methyl-d-aspartate receptor and Parkinson's disease: A hypothesis
- (2013) Uriel Heresco-Levy et al. MOVEMENT DISORDERS
- AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study
- (2013) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in l-DOPA-treated parkinsonian monkeys
- (2013) Nicolas Morin et al. NEUROPHARMACOLOGY
- Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
- (2013) Fabrizio Gasparini et al. Parkinsons Disease
- Glutamate Receptors as Therapeutic Targets for Parkinsons Disease
- (2012) Kari Johnson et al. CNS & Neurological Disorders-Drug Targets
- New pharmacological avenues for the treatment ofl-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors
- (2012) Fabio Blandini et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease
- (2012) V. Bagetta et al. JOURNAL OF NEUROSCIENCE
- Effect of chronic l-DOPA treatment on 5-HT1A receptors in parkinsonian monkey brain
- (2012) Golnasim Riahi et al. NEUROCHEMISTRY INTERNATIONAL
- MPEP, an mGlu5 receptor antagonist, reduces the development of l-DOPA-induced motor complications in de novo parkinsonian monkeys: Biochemical correlates
- (2012) Nicolas Morin et al. NEUROPHARMACOLOGY
- Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia
- (2012) Khaled-Ezaheir Bennouar et al. NEUROPHARMACOLOGY
- Brain 5-HT2A receptors in MPTP monkeys and levodopa-induced dyskinesias
- (2011) Golnasim Riahi et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Higher free d-aspartate and N-methyl-d-aspartate levels prevent striatal depotentiation and anticipate l-DOPA-induced dyskinesia
- (2011) Francesco Errico et al. EXPERIMENTAL NEUROLOGY
- Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation
- (2011) Mahmoud M. Iravani et al. JOURNAL OF NEURAL TRANSMISSION
- AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials
- (2011) Daniela Berg et al. MOVEMENT DISORDERS
- Priorities in Parkinson's disease research
- (2011) Wassilios G. Meissner et al. NATURE REVIEWS DRUG DISCOVERY
- The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in l-Dopa-treated parkinsonian monkeys
- (2011) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
- (2011) Hideyuki Sawada et al. PLoS One
- Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia
- (2010) Daniella Rylander et al. ANNALS OF NEUROLOGY
- Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
- (2010) Colleen M. Niswender et al. Annual Review of Pharmacology and Toxicology
- Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson’s disease
- (2010) Christopher Kobylecki et al. JOURNAL OF NEUROCHEMISTRY
- Effect of l-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys
- (2010) Bazoumana Ouattara et al. JOURNAL OF NEUROCHEMISTRY
- Reduction of L-DOPA-Induced Dyskinesia by the Selective Metabotropic Glutamate Receptor 5 Antagonist 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
- (2010) T. H. Johnston et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys
- (2010) Daniella Rylander et al. NEUROBIOLOGY OF DISEASE
- Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys
- (2010) Nicolas Morin et al. NEUROPHARMACOLOGY
- Antagonists at Metabotropic Glutamate Receptor Subtype 5
- (2009) F. Ivy Carroll Annals of the New York Academy of Sciences
- Metabotropic Glutamate Receptor II in the Brains of Parkinsonian Patients
- (2009) Pershia Samadi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation
- (2009) C. Malagelada et al. JOURNAL OF NEUROSCIENCE
- Metabotropic Glutamate 7 Receptor Subtype Modulates Motor Symptoms in Rodent Models of Parkinson's Disease
- (2009) B. Greco et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pharmacological Modulation of Glutamate Transmission in a Rat Model of L-DOPA-Induced Dyskinesia: Effects on Motor Behavior and Striatal Nuclear Signaling
- (2009) D. Rylander et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Metabotropic glutamate receptor type 5 in levodopa-induced motor complications
- (2009) Bazoumana Ouattara et al. NEUROBIOLOGY OF AGING
- The scientific and clinical basis for the treatment of Parkinson disease (2009)
- (2009) C. W. Olanow et al. NEUROLOGY
- Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of l-Dopa in parkinsonian monkeys
- (2009) Laurent Grégoire et al. PARKINSONISM & RELATED DISORDERS
- Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys
- (2009) Marc Morissette et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Inhibition of mTOR Signaling in Parkinson's Disease Prevents L-DOPA-Induced Dyskinesia
- (2009) E. Santini et al. Science Signaling
- Receptor–receptor interactions within receptor mosaics. Impact on neuropsychopharmacology
- (2008) K. Fuxe et al. BRAIN RESEARCH REVIEWS
- Treatment of levodopa-induced motor complications
- (2008) Fabrizio Stocchi et al. MOVEMENT DISORDERS
- Molecular mechanisms of L-DOPA-induced dyskinesia
- (2008) Peter Jenner NATURE REVIEWS NEUROSCIENCE
- Association between AKT1 gene and Parkinson's disease: A protective haplotype
- (2008) Georgia Xiromerisiou et al. NEUROSCIENCE LETTERS
- Progress in Parkinson's disease—Where do we stand?
- (2008) André Toulouse et al. PROGRESS IN NEUROBIOLOGY
- Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys
- (2007) L GREGOIRE et al. BEHAVIOURAL BRAIN RESEARCH
- Group III metabotropic glutamate receptors act as hetero-receptors modulating evoked GABA release in the globus pallidus in vivo
- (2007) Nicholas MacInnes et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys
- (2007) Pershia Samadi et al. NEUROBIOLOGY OF AGING
- Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease
- (2007) Giovanna Levandis et al. NEUROBIOLOGY OF DISEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now